Evaluation of Potential Living Kidney Donors in the Era.
作者信息
Freedman Barry I, Julian Bruce A
机构信息
Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina; and
Department of Medicine, Division of Nephrology; University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
出版信息
J Am Soc Nephrol. 2018 Apr;29(4):1079-1081. doi: 10.1681/ASN.2018020137. Epub 2018 Mar 9.
Abstract
摘要
相似文献
1
Evaluation of Potential Living Kidney Donors in the Era.评估当代潜在活体肾供者。
J Am Soc Nephrol. 2018 Apr;29(4):1079-1081. doi: 10.1681/ASN.2018020137. Epub 2018 Mar 9.
2
Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.检测潜在活体肾脏供者中的高危 APOL1 等位基因。
Am J Kidney Dis. 2015 Sep;66(3):396-401. doi: 10.1053/j.ajkd.2015.04.046. Epub 2015 Jun 3.
3
Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients.载脂蛋白 L1 在非裔美国活体肾供者、肾移植患者和非患者中的观点。
J Surg Res. 2022 Sep;277:116-124. doi: 10.1016/j.jss.2022.04.011. Epub 2022 Apr 27.
4
African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study.非裔美国活体捐献者对 APOL1 基因检测的态度：一项混合方法研究。
Am J Kidney Dis. 2018 Dec;72(6):819-833. doi: 10.1053/j.ajkd.2018.07.017. Epub 2018 Oct 22.
5
Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.活体肾捐献者评估中 APOL1 基因分型的实用考虑。
Transplantation. 2020 Jan;104(1):27-32. doi: 10.1097/TP.0000000000002933.
6
Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study.介绍活体肾移植中意义不确定的基因检测：以载脂蛋白L1为例进行研究
Prog Transplant. 2016 Sep;26(3):203-6. doi: 10.1177/1526924816654608. Epub 2016 Jun 14.
7
APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness.APOL1 基因分型在潜在非裔美国活体肾脏供者中的应用：效用和成本效益。
Am J Nephrol. 2020;51(2):116-118. doi: 10.1159/000505719. Epub 2020 Jan 15.
8
Genotype and Renal Function of Black Living Donors.黑人活体供者的基因型与肾功能。
J Am Soc Nephrol. 2018 Apr;29(4):1309-1316. doi: 10.1681/ASN.2017060658. Epub 2018 Jan 16.
9
Apolipoprotein L1 Gene Effects on Kidney Transplantation.载脂蛋白 L1 基因对肾移植的影响。
Semin Nephrol. 2017 Nov;37(6):530-537. doi: 10.1016/j.semnephrol.2017.07.006.
10
APOL1 Genetic Testing in Living Kidney Transplant Donors.APOL1 基因检测在活体肾移植供者中的应用。
Am J Kidney Dis. 2019 Oct;74(4):538-543. doi: 10.1053/j.ajkd.2019.02.007. Epub 2019 Apr 11.
引用本文的文献
1
Screening of Living Kidney Donors for Genetic Diseases: Commentary.活体肾供体的遗传病筛查：评论
Kidney360. 2024 Oct 1;5(10):1419-1421. doi: 10.34067/KID.0000000000000470. Epub 2024 May 15.
2
Apolipoprotein L1: role in the evaluation of kidney transplant donors.载脂蛋白 L1：在评估肾移植供体中的作用。
Curr Opin Nephrol Hypertens. 2020 Nov;29(6):645-655. doi: 10.1097/MNH.0000000000000653.
3
Digital pathology and computational image analysis in nephropathology.数字病理学和肾脏病学中的计算图像分析。
Nat Rev Nephrol. 2020 Nov;16(11):669-685. doi: 10.1038/s41581-020-0321-6. Epub 2020 Aug 26.
4
Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation.非裔美国成年人对活体肾脏捐献和移植中使用载脂蛋白 L1（ApoL1）基因检测的看法。
Am J Transplant. 2021 Mar;21(3):1197-1205. doi: 10.1111/ajt.16206. Epub 2020 Aug 29.
本文引用的文献
1
Genotype and Renal Function of Black Living Donors.黑人活体供者的基因型与肾功能。
J Am Soc Nephrol. 2018 Apr;29(4):1309-1316. doi: 10.1681/ASN.2017060658. Epub 2018 Jan 16.
2
Apolipoprotein L1 Gene Effects on Kidney Transplantation.载脂蛋白 L1 基因对肾移植的影响。
Semin Nephrol. 2017 Nov;37(6):530-537. doi: 10.1016/j.semnephrol.2017.07.006.
3
Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.载脂蛋白 L1 与年轻潜在活体供肾者的慢性肾脏病风险。
Ann Surg. 2018 Jun;267(6):1161-1168. doi: 10.1097/SLA.0000000000002174.
4
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.载脂蛋白L1（APOL1）基因型与非裔美国已故捐赠者的肾移植结果
Transplantation. 2016 Jan;100(1):194-202. doi: 10.1097/TP.0000000000000969.
5
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.活体肾供体候选人的肾衰竭风险预测
N Engl J Med. 2016 Feb 4;374(5):411-21. doi: 10.1056/NEJMoa1510491. Epub 2015 Nov 6.
6
Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.载脂蛋白L1基因相关性肾病中的基因-基因及基因-环境相互作用
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):2006-13. doi: 10.2215/CJN.01330214. Epub 2014 Jun 5.
7
APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair.APOL1 多态性与同卵双胞胎供受者肾疾病的发生。
Am J Kidney Dis. 2014 May;63(5):816-9. doi: 10.1053/j.ajkd.2013.12.014. Epub 2014 Feb 8.
8
The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.非裔美国肾移植受者的 APOL1 基因型不影响 5 年移植物存活率。
Am J Transplant. 2012 Jul;12(7):1924-8. doi: 10.1111/j.1600-6143.2012.04033.x. Epub 2012 Apr 4.
9
The APOL1 gene and allograft survival after kidney transplantation.APOL1 基因与肾移植后移植物的存活。
Am J Transplant. 2011 May;11(5):1025-30. doi: 10.1111/j.1600-6143.2011.03513.x. Epub 2011 Apr 12.
10
Association of trypanolytic ApoL1 variants with kidney disease in African Americans.载脂蛋白 L1 变体与非裔美国人肾脏疾病的关联。
Science. 2010 Aug 13;329(5993):841-5. doi: 10.1126/science.1193032. Epub 2010 Jul 15.
Zotero 插件